SHUNIAN HE: Open Payments
NPI 1740207471 · MARLBOROUGH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 61 payments from 17 companies in 2025. Trend: 2023 $1,144 · 2024 $1,382 · 2025 $1,371
Food & beverage: $1,371
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $280 |
| ABBVIE INC. | 8 | $148 |
| Otsuka America Pharmaceutical, Inc. | 6 | $131 |
| Lundbeck LLC | 4 | $108 |
| Novo Nordisk Inc | 4 | $99 |
| PFIZER INC. | 5 | $91 |
| Lilly USA, LLC | 3 | $75 |
| Amgen Inc. | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 3 | $69 |
| Ardelyx, Inc. | 3 | $66 |
Products named: REXULTI, AIRSUPRA, MOUNJARO, UBRELVY, VOQUEZNA, IBSRELA, Wegovy, FARXIGA.
Industry payments across MA — which companies pay providers there.
